Hemangiomas of the nasal tip: An approach to a therapeutic challenge

Eivazi, Behfar; Cremer, H; Mangold, C.; Teymoortash, Afshin; Wiegand, Susanne; Werner, Jochen A.

doi:10.1016/j.ijporl.2010.12.007

Cited by 22 publications

(26 citation statements)

References 17 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Aesthetic problem is usually obvious. Eivazi et al classified nasal tip hemangiomas as "limited" or "advanced" [25]. Hamou et al identify three types of nasal hemangiomas that lead to three distinct surgical approaches: -Type A (mild cases): no cutaneous involvement, no misalignment of the cartilages an mild nasal volume increase -Type B (moderate cases): partial cutaneous infiltration, misalignment of the cartilages and moderate nasal volume increase -Type C (severe cases): cutaneous infiltration, misalignment of the cartilages and severe nasal volume increase [31].…”

Section: Nasal Hemangiomasmentioning

confidence: 99%

“…The treatment choices of nasal hemangiomas are still controversial considering use of preoperative medical treatment, timing of surgery, surgical approach and necessity of skin resection [15,27]. Pharmacological, surgical or laser interventions are current treatment options for nasal hemangiomas [13][14][15][16][17][18][19][20][21][22][23][24][25][26][27]. A "no-touch" or conservative approach for the treatment of nasal hemangiomas was previously advocated with frequent consultations with the parents to furnish psychological support [26].…”

Section: Treatment Optionsmentioning

confidence: 99%

“…The management of hemangioma is an area of great controversy [6]. Current options are conservative treatment (corticosteroids, interferons, hemiotherapy, propranolol), laser treatment, and surgical treatment [6,[9][10][11][12][13][14][15][16][17][18][19][20][21][22][23][24][25][26][27]. Corticosteroids were generally accepted to be the first-line therapy for hemangiomas [6].…”

mentioning

confidence: 99%

“…Recently propranolol proved itself effective in inducing regression of growing hemangioma. There are several reports confirming prompt response of hemangioma to propranolol with no major side effects [23,25,28,29]. There are three questions regarding surgical intervention: 1) what are the indications, 2) when it should be done (timing) and 3) how it should be done [30].…”

mentioning

confidence: 99%

See 3 more Smart Citations

Surgical Management of Nasal Hemangiomas

Vlahovic¹

2011

Rhinoplasty

View full text Add to dashboard Cite

Section: Nasal Hemangiomasmentioning

confidence: 99%

Section: Treatment Optionsmentioning

confidence: 99%

mentioning

confidence: 99%

mentioning

confidence: 99%

See 2 more Smart Citations

Surgical Management of Nasal Hemangiomas

Vlahovic¹

2011

Rhinoplasty

View full text Add to dashboard Cite

“…These include observation, corticosteroids (systemic, intralesional), sclerotherapy, interferon _2α, laser therapy, vincristine, Beta-blockers,and surgical treatment. 11 The aim of this study was to identify those lesions that are most likely to require treatment and how to select the treatment modality that is best suited for a particular individual with emphasis on the timing of intervention, particularly focusing on outcomes following various managements (steroid or surgical treatment), to enable plastic and maxillofacial surgeon to develop an approach in the management of these esthetically, functionally, and psychosocially compromising congenital vascular tumor. 9 of observation, steroid, surgical excision or combined therapy.…”

mentioning

confidence: 99%

Evaluation of hemangioma management in Erbil city

Fattah¹,

Kaka²

2015

ZJMS

View full text Add to dashboard Cite

Modern Management of Nasal Hemangiomas

Keller

Stevens

Hochman³

2017

JAMA Facial Plast Surg

View full text Add to dashboard Cite

here is a wealth of literature dedicated to the pathogenesis, diagnosis, and clinical behavior of infantile hemangiomas (IHs), which are the most common benign tumors of infancy. Therapeutic strategies, however, are less well studied, and continue to evolve as laser, surgical, and medical interventions are refined to attain the best cosmetic and functional outcomes. Infantile hemangiomas of the nose (IHNs) comprise a special subset of these tumors owing to their effect on a structure with known functional, aesthetic, and psychosocial importance. Because of the relatively low incidence of IHNs, the timing, type, duration, and extent of treatment are topics of debate. Recently, a more aggressive approach for a wider range of tumors has been gaining strength because of the excellent efficacy and safety profile of β-blockers and the availability of a US Food and Drug Administration-approved formulation for infants with IHs. [1][2][3] The paucity of outcomes data for management of IHN, however, makes planning of generalized treatment difficult. Because of this difficulty, we hypothesized that a standardized therapeutic protocol for IHNs that is capable of achieving acceptable aesthetic and functional outcomes by 2.5 to 3 years of age (when a sense of self begins to form) could be developed from consensus literature reports and personal experience. 1,4 To address this hypothesis, we performed a retrospective record review of treatment approaches and outcomes in our patient population and compared this experience with that in the literature. Methods Primary StudyWe performed a retrospective review of all patients with IHNs treated by a single surgeon (M.H.) in a tertiary referral private practice between January 1, 1999, and December 31, 2015. Inclusion criteria were diagnosis of IHN, documentation of medical and/or surgical interventions, and duration of follow-up of 1 year or more. Patients were excluded if management consisted solely of observation for tumors or anomalies other than IHNs and if the IHN was confined solely to the glabella. Patient records were mined for demographic data, tumor-specific variables, clinical data, therapeutic interventions, and outcomes. Tumor-specific variables were as follows: (1) depth of involvement, characterized as superficial lesions extending to the dermis only, deep lesions confined to the subcutaneous or subdermal tissue, and compound lesions with simultaneous superficial and deep components; (2) tumor distribution, characterized as focal tumors involved in solitary nasal subunits and segmental tumors involved in multifocal and/or dermatomal distributions; and (3) tumor life IMPORTANCE Current treatment approaches for infantile hemangiomas of the nose include observation, pharmacologic agents, surgery, and/or laser therapy. Because of the known functional, social, and cosmetic effect of nasal deformities, obtaining the best possible result is critical. Optimal timing, type, duration, and extent of therapy remain unclear.OBSERVATIONS Results of a review of 86 patients (64 female...

show abstract

Hemangiomas of the nasal tip: An approach to a therapeutic challenge

Cited by 22 publications

References 17 publications

Surgical Management of Nasal Hemangiomas

Surgical Management of Nasal Hemangiomas

Evaluation of hemangioma management in Erbil city

Modern Management of Nasal Hemangiomas

Contact Info

Product

Resources

About